Sciatica Market Key players- Endo Pharmaceuticals, AstraZeneca, Novartis AG and Teva Pharmaceutical Industries Market study and Forecast 2017-2023

Market Synopsis of Global Sciatica Market

Market Scenario

Sciatica is characterized by pain going down the leg from the lower back due to irritation of the lumbar or sacral nerves. Sciatica is triggered by activities like heavy lifting and jerky movements. However the condition can also develop gradually. Typically, sciatica symptoms occur on one side of the body although in some cases the pain can be on both sides. The other symptoms of sciatica are weakness or numbness in the affected leg, burning or tingling down the affected leg, and constant pain on one side of the rear. The causes of sciatica are spondylolisthesis, muscle spasm in the back or buttock, spinal stenosis, piriformis syndrome, pelvic tumours, pregnancy and others. However, spinal disc herniation is the primary cause of sciatica in about 90% of the cases. Other uncommon causes are lumbar degenerative disc disease, osteophytes and arthritis of the spine.

View Reports Sample @ https://www.marketresearchfuture.com/sample_request/4767



Sciatica generally resolves on its own in about 90% of the cases. However it can result in severe pain which may need surgical intervention. Surgery may be required if complications occur such as bowel or bladder problems. Sciatica affects 40% of people at some point in their life time. Sciatica is most common during people's 40s and 50s, and men are more frequently affected than women.

The market drivers for global sciatica market are rise in demand due to growing population, increasing screening, rising cases of geriatrics, rising safety and success of drug treatment, the extricating nature of the pain and others. The market restraints are the complications of surgery such as risk of bleeding, infections, pain, high cost of sciatica treatment, and others.

The global sciatica market is expected to reach USD 18.9 billion by 2023, and the market is projected to grow at a CAGR of ~ 8.0 % during the forecast period 2017-2023.

Intended Audience

Global Sciatica manufacturers & suppliers
Research and development (R&D) companies
Hospitals and clinics
Academic institutes and universities
Segments

The global sciatica market has been segmented on the basis of types, drug treatment, devices and end user.

Based on the types, the market has been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root sciatica and others.

Based on the drugs, the market has been segmented as anesthetics, pain killers, muscle relaxants, antidepressants, steroids and others.

Based on the non-drug treatment, the market has been segmented as physiotherapy, acupuncture, stimulation devices, surgery and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.

Regional Analysis

The Americas accounts for a significant market share owing to high expenditure on the healthcare especially of the U.S. and Canada. Additionally, greater number of orthopedic procedures due to greater healthcare penetration in the U.S. and Canada drives the sciatica market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgical procedures especially the sciatica treatment in the returns of hospitals favors the market. A large number of medical devices companies in the U.S. is also a cause for the faster development of sciatica market in the US.

Europe is the second largest market in the world due to the growing medical devices industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry.

Asia Pacific region is expected to grow rapidly where China and India are likely to lead the market due to faster growing healthcare sector and larger unmet needs over the forecast period. The South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future sciatica market in the region.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle Eastern nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.

Request Full Report @ https://www.marketresearchfuture.com/reports/sciatica-market-4767



Key Players in the Global Sciatica Market

Some of the key players profiled in the report are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi and others.

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India